These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12461324)

  • 1. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy.
    Sica DA; Black HR
    Congest Heart Fail; 2002; 8(6):334-41, 345. PubMed ID: 12461324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?
    Sica DA; Black HR
    J Clin Hypertens (Greenwich); 2002; 4(5):375-80. PubMed ID: 12368584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema.
    Fuchs SA; Meyboom RH; van Puijenbroek EP; Guchelaar HJ
    Pharm World Sci; 2004 Aug; 26(4):191-2. PubMed ID: 15446773
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
    Abdi R; Dong VM; Lee CJ; Ntoso KA
    Pharmacotherapy; 2002 Sep; 22(9):1173-5. PubMed ID: 12222553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
    Warner KK; Visconti JA; Tschampel MM
    Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors.
    Eworuke E; Welch EC; Haug N; Horgan C; Lee HS; Zhao Y; Huang TY
    J Am Coll Cardiol; 2023 Jan; 81(4):321-331. PubMed ID: 36697132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.
    Cicardi M; Zingale LC; Bergamaschini L; Agostoni A
    Arch Intern Med; 2004 Apr; 164(8):910-3. PubMed ID: 15111379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced angioedema without urticaria.
    Agostoni A; Cicardi M
    Drug Saf; 2001; 24(8):599-606. PubMed ID: 11480492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.
    Makani H; Messerli FH; Romero J; Wever-Pinzon O; Korniyenko A; Berrios RS; Bangalore S
    Am J Cardiol; 2012 Aug; 110(3):383-91. PubMed ID: 22521308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-receptor blockers: clinical relevance and therapeutic role.
    Rodgers JE; Patterson JH
    Am J Health Syst Pharm; 2001 Apr; 58(8):671-83. PubMed ID: 11329759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Cough and Angioedema: Advocating for the Use of ARBs Over ACE Inhibitors.
    Lam M; Beqo A; Thumar R
    Ann Pharmacother; 2022 Mar; 56(3):358-362. PubMed ID: 34192890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Malde B; Regalado J; Greenberger PA
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioedema related to Angiotensin inhibitors.
    Knecht SE; Dunn SP; Macaulay TE
    J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.
    Düsing R; Sellers F
    Curr Med Res Opin; 2009 Sep; 25(9):2287-301. PubMed ID: 19635044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights.
    Cutrell S; Alhomoud IS; Mehta A; Talasaz AH; Van Tassell B; Dixon DL
    Curr Hypertens Rep; 2023 Sep; 25(9):243-250. PubMed ID: 37284934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioral angioedema associated with angiotensin-converting enzyme inhibitor.
    Peacock ME; Park DS; Swiec GD; Erley KJ
    J Periodontol; 2005 Apr; 76(4):651-4. PubMed ID: 15857108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor-induced angioedema.
    Bezalel S; Mahlab-Guri K; Asher I; Werner B; Sthoeger ZM
    Am J Med; 2015 Feb; 128(2):120-5. PubMed ID: 25058867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.